Home > Products > BAFF & IL17
> Recombinant Anti-BAFF x Anti-IL17 Bispecific Antibody (Fv-IgG)
Recombinant Anti-BAFF x Anti-IL17 Bispecific Antibody (Fv-IgG) (CAT#: BSDG-019)
Recombinant Anti-BAFF x Anti-IL17 Bispecific Antibody (Fv-IgG) is an appended IgG format, which has 2+2 antigen-binding valency. This dual variable domain IgG is generated by appending variable domains of an anti-BAFF IgG with similar domains from an anti-IL17 antibody via short peptide linkers, or vice versa. This BsAb can neutralize both BAFF and IL- 17 simultaneously. It is designed for the research of Lupus Nephritis (LN); Systemic Lupus Erythematosus (SLE); Rheumatoid Arthritis (RA); Psoriasis (Ps); Ankylosing Spondylitis (AS); Psoriatic Arthritis (PA) primary Sjögren's Syndrome (pSS); Multiple Myeloma (MM) therapy.
There are currently no customer reviews or questions for Recombinant Anti-BAFF x Anti-IL17 Bispecific Antibody (Fv-IgG) (BSDG-019). Click the button below to contact us or submit your feedback about this product.